119 related articles for article (PubMed ID: 3623958)
1. Radioimmunoscintigraphy of squamous carcinomas of the head and neck.
Soo KC; Ward M; Roberts KR; Keeling F; Carter RL; McCready VR; Ott RJ; Powell E; Ozanne B; Westwood JH
Head Neck Surg; 1987; 9(6):349-52. PubMed ID: 3623958
[TBL] [Abstract][Full Text] [Related]
2. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.
Divgi CR; Welt S; Kris M; Real FX; Yeh SD; Gralla R; Merchant B; Schweighart S; Unger M; Larson SM
J Natl Cancer Inst; 1991 Jan; 83(2):97-104. PubMed ID: 1988695
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
Hoeben BA; Molkenboer-Kuenen JD; Oyen WJ; Peeters WJ; Kaanders JH; Bussink J; Boerman OC
Int J Cancer; 2011 Aug; 129(4):870-8. PubMed ID: 20957635
[TBL] [Abstract][Full Text] [Related]
5. Imaging of pharyngeal and laryngeal carcinomas with indium-111-labeled monoclonal anti-CEA antibodies.
Kairemo KJ; Hopsu EV
Laryngoscope; 1990 Oct; 100(10 Pt 1):1077-82. PubMed ID: 2215039
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region.
Heissler E; Grünert B; Barzen G; Fritsche L; Hell B; Felix R; Bier J
Int J Oral Maxillofac Surg; 1994 Jun; 23(3):149-52. PubMed ID: 7930767
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunolocalization of head and neck tumors with a new monoclonal antibody against the EGF receptor. Preliminary results].
Oliva JP; Cruz T; Pimentel G; Quesada W; Ortiz R; Abreu M; Sánchez I; Díaz N; Baum RP
Rev Esp Med Nucl; 2004; 23(4):273-8. PubMed ID: 15207212
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent.
Goodwin DA; Meares CF; DeRiemer LH; Diamanti CI; Goode RL; Baumert JE; Sartoris DJ; Lantieri RL; Fawcett HD
J Nucl Med; 1981 Sep; 22(9):787-92. PubMed ID: 6168750
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodiagnosis of human-derived squamous cell carcinoma.
Wahl RL; Kimmel KA; Beierwaltes WH; Carey TE
Hybridoma; 1987 Apr; 6(2):111-9. PubMed ID: 3570303
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
Modjtahedi H; Hickish T; Nicolson M; Moore J; Styles J; Eccles S; Jackson E; Salter J; Sloane J; Spencer L; Priest K; Smith I; Dean C; Gore M
Br J Cancer; 1996 Jan; 73(2):228-35. PubMed ID: 8546911
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer localization with indium labelled carcinoembryonic antigen: a pilot project.
Timon CI; McShane D; Hamilton D; Walsh MA
J Otolaryngol; 1991 Aug; 20(4):283-7. PubMed ID: 1920585
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection of head and neck cancer. A review.
Hopsu EV; Kairemo KJ
Acta Oncol; 1993; 32(7-8):735-40. PubMed ID: 8305220
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic evaluation of Ga67 scanning of recurrences of head and neck carcinomas.
Basso-Ricci S; Turrin A
Rays; 1985; 10(2):103-8. PubMed ID: 3870489
[No Abstract] [Full Text] [Related]
15. Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.
Quak JJ; Balm AJ; Brakkee JG; Scheper RJ; Haisma HJ; Braakhuis BJ; Meijer CJ; Snow GB
Int J Cancer; 1989 Sep; 44(3):534-8. PubMed ID: 2777416
[TBL] [Abstract][Full Text] [Related]
16. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
17. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
Radiother Oncol; 1997 Sep; 44(3):283-93. PubMed ID: 9380829
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice.
Yang K; Zhao C; Cao YA; Tang H; Bai YL; Huang H; Zhao CR; Chen R; Zhao D
Oncol Rep; 2012 Jun; 27(6):1925-31. PubMed ID: 22378320
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer.
Wheeler RH; Spencer S; Buchsbaum D; Robert F
Curr Opin Oncol; 1999 May; 11(3):187-90. PubMed ID: 10328593
[TBL] [Abstract][Full Text] [Related]
20. Experiences with 197HgCl2 in the diagnosis of head and neck malignancies.
Aversa C; Fiamminghi L; Gennari PU; Bertani A
J Maxillofac Surg; 1978 May; 6(2):93-7. PubMed ID: 276557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
